cryoem-ai-drug-design-agent

Core Capabilities

1. Density-Guided Design: Fit ligands into cryo-EM density maps.

2. AlphaFold Integration: Combine AF3 predictions with EM data.

3. Flexible Docking: Account for protein dynamics in binding.

4. Fragment Screening: Virtual fragment screening with EM structures.

5. Complex Targeting: Design for multi-protein assemblies.

6. Dynamics-Based Design: Incorporate conformational flexibility.

Cryo-EM for Drug Discovery

Target Class	Cryo-EM Advantage	Drug Discovery Application
GPCRs	Native lipid environment	Allosteric sites
Ion Channels	Multiple conformations	State-specific design
Transporters	Conformational states	Mechanism-based
Ribosomes	Antibiotic binding	New antibiotics
Viral Proteins	Large assemblies	Vaccines, antivirals
Intrinsically Disordered	Flexible regions	Challenging targets

Workflow

1. Input: Cryo-EM density map, protein sequence, ligand/fragment.

2. Structure Refinement: AlphaFold + density-guided refinement.

3. Binding Site Identification: Detect pockets in EM structure.

4. Ligand Placement: Density-guided ligand fitting.

5. MD Simulation: Flexible binding simulation.

6. Optimization: Generative design around hits.

7. Output: Optimized ligands, binding models, design recommendations.